Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2015-07-22 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: REIMS (51100), Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA CERISAIE : revenue, balance sheet and financial ratios
PHARMACIE DE LA CERISAIE is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in REIMS (51100),
this company of category PME
shows in 2025 a net income positive of 39 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA CERISAIE (SIREN 812676054)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
39 138 €
35 315 €
33 159 €
106 421 €
106 928 €
76 249 €
79 285 €
83 537 €
62 206 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE LA CERISAIE generates positive net income of 39 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 62 k€ -> 39 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
39 138 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 27%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
27.279%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
64.933%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA CERISAIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
415.899
253.257
172.593
119.205
82.285
59.095
48.251
37.113
27.279
Financial autonomy
17.088
24.841
32.528
40.585
48.373
55.0
58.016
62.039
64.933
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
27.282025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-6 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE LA CERISAIE (27.28) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
64.93%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good
In 2025, the financial autonomy of PHARMACIE DE LA CERISAIE (64.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 175.09. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
175.088
Liquidity indicators evolution PHARMACIE DE LA CERISAIE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
221.393
238.105
256.403
241.866
264.401
284.865
253.396
201.774
175.088
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
175.092025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average-23 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE LA CERISAIE (175.09) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE DE LA CERISAIE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA CERISAIE is estimated at
621 711 €
(range 421 896€ - 975 551€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
421k€621k€975k€
621 711 €Range: 421 896€ - 975 551€
NAF 5 année 2025
Valuation method used
Net Income Multiple
39 138 €
×
15.9x
=621 712 €
Range: 421 897€ - 975 551€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA CERISAIE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA CERISAIE
What is the revenue of PHARMACIE DE LA CERISAIE ?
The revenue of PHARMACIE DE LA CERISAIE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE LA CERISAIE profitable?
Yes, PHARMACIE DE LA CERISAIE generated a net profit of 39 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA CERISAIE ?
The headquarters of PHARMACIE DE LA CERISAIE is located in REIMS (51100), in the department Marne.
Where to find the tax return of PHARMACIE DE LA CERISAIE ?
The tax return of PHARMACIE DE LA CERISAIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA CERISAIE operate?
PHARMACIE DE LA CERISAIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart